# Gilead Sciences vs Thermo Fisher Scientific: stocks compared

URL: https://funkfolio.com/compare/gild-vs-tmo

> Gilead Sciences ($211.2B) and Thermo Fisher Scientific ($254.5B, P/E 36.2) compared: size, valuation, margins, debt, cash and price change.

---

## Gilead Sciences vs Thermo Fisher Scientific

Gilead Sciences (GILD), health care, and Thermo Fisher Scientific (TMO), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Thermo Fisher Scientific is worth $254.5B on the stock market and Gilead Sciences $211.2B: Thermo Fisher Scientific is valued at 20% more. Gilead Sciences's operating margin in its latest fiscal year was 34.0% and Thermo Fisher Scientific's 17.4%. Over the past year Gilead Sciences's share price has moved +31.8% and Thermo Fisher Scientific's +20.0%.

### Key facts

- **Gilead Sciences market value:** $211.2B
- **Thermo Fisher Scientific market value:** $254.5B
- **Thermo Fisher Scientific P/E:** 36.2
- **Gilead Sciences revenue:** $29.4B FY to 2025-12-31
- **Thermo Fisher Scientific revenue:** $44.6B FY to 2025-12-31
- **Superinvestors holding both:** 4

Market values as of 18 Nov 2026, 02:41 UTC.

Gilead Sciences vs Thermo Fisher Scientific: every measure side by side

| Measure | Gilead Sciences | Thermo Fisher Scientific |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | United States | United States |
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size |  |  |
| Market cap | $211.2B lower | $254.5B higher |
| Revenue | $29.4B lower | $44.6B higher |
| Earnings | $8.5B higher | $6.7B lower |
| Employees | 17,000 lower | 125,000 higher |
| Total assets | $59B lower | $110.3B higher |
| Valuation |  |  |
| P/E | — | 36.2 |
| P/S | 7.2 higher | 5.7 lower |
| P/B | 16.2 higher | 4.6 lower |
| Dividend yield | 1.94% higher | 0.27% lower |
| Profitability |  |  |
| Operating margin | 34.0% higher | 17.4% lower |
| Balance sheet |  |  |
| Net assets | $22.7B lower | $53.4B higher |
| Total liabilities | $36.4B lower | $56.8B higher |
| Total debt | $24.9B lower | $39.4B higher |
| Cash on hand | $7.6B lower | $9.9B higher |
| Price change |  |  |
| Today | +1.60% higher | -0.66% lower |
| 1 year | +31.8% higher | +20.0% lower |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: Gilead Sciences 137.2, Thermo Fisher Scientific 121.1.

- Gilead Sciences (GILD)
- Thermo Fisher Scientific (TMO)

Gilead Sciences and Thermo Fisher Scientific share prices over one year, rebased to 100: Gilead Sciences ends at 137.2, Thermo Fisher Scientific at 121.1.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | GILD | TMO |
| --- | --- | --- |
| Nov 28, 2025 | 101.4 | 104.2 |
| Dec 31, 2025 | 98.9 | 102.2 |
| Jan 30, 2026 | 114.4 | 102.0 |
| Feb 27, 2026 | 120.0 | 91.9 |
| Mar 31, 2026 | 112.3 | 86.7 |
| Apr 30, 2026 | 105.4 | 84.4 |
| May 29, 2026 | 108.3 | 86.8 |
| Jun 30, 2026 | 101.8 | 88.4 |
| Jul 31, 2026 | 104.9 | 101.3 |
| Aug 31, 2026 | 117.9 | 108.8 |
| Sep 30, 2026 | 120.1 | 119.0 |
| Oct 30, 2026 | 137.5 | 122.9 |
| Nov 17, 2026 | 137.2 | 121.1 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (4)

- [Dodge & Cox team](https://funkfolio.com/gurus/dodge-and-cox) 1.7% / 1.1%
- [Steve Cohen](https://funkfolio.com/gurus/steve-cohen) 0.3% / 0.2%
- [Ken Griffin](https://funkfolio.com/gurus/ken-griffin) 0.3% / 0.2%
- [David Shaw (founder)](https://funkfolio.com/gurus/david-shaw) 0.2% / 0.2%

#### Gilead Sciences only (6)

- [Brandon Haley](https://funkfolio.com/gurus/brandon-haley) 0.9%
- [Josef Lakonishok](https://funkfolio.com/gurus/josef-lakonishok) 0.7%
- [Jim Simons (1938–2024)](https://funkfolio.com/gurus/jim-simons) 0.4%
- [John Rogers](https://funkfolio.com/gurus/john-rogers) 0.3%
- [Fred DiSanto](https://funkfolio.com/gurus/fred-disanto) 0.3%
- [Ray Dalio (founder)](https://funkfolio.com/gurus/bridgewater) 0.2%

#### Thermo Fisher Scientific only (20)

- [Nick Train](https://funkfolio.com/gurus/nick-train) 12.4%
- [Larry Robbins](https://funkfolio.com/gurus/larry-robbins) 6.3%
- [Wallace Weitz](https://funkfolio.com/gurus/wallace-weitz) 4.9%
- [Jeremy Grantham (co-founder)](https://funkfolio.com/gurus/jeremy-grantham) 4.3%
- [Andreas Halvorsen](https://funkfolio.com/gurus/andreas-halvorsen) 2.8%
- [Harry Burn](https://funkfolio.com/gurus/harry-burn) 2.7%
- [Temasek](https://funkfolio.com/gurus/temasek) 2.2%
- [Doug Silverman](https://funkfolio.com/gurus/doug-silverman) 2.0%
- [Steven Romick](https://funkfolio.com/gurus/steven-romick) 2.0%
- [Diamond Hill team](https://funkfolio.com/gurus/diamond-hill) 1.6%
- [Andrew Spokes](https://funkfolio.com/gurus/farallon) 1.6%
- [John Armitage](https://funkfolio.com/gurus/john-armitage) 1.4%
- [Primecap team](https://funkfolio.com/gurus/primecap) 0.8%
- [Daniel Sundheim](https://funkfolio.com/gurus/daniel-sundheim) 0.7%
- [Ken Fisher](https://funkfolio.com/gurus/ken-fisher) 0.6%
- [Tom Gayner](https://funkfolio.com/gurus/tom-gayner) 0.4%
- [Baillie Gifford team](https://funkfolio.com/gurus/baillie-gifford) 0.4%
- [Stanley Druckenmiller](https://funkfolio.com/gurus/stanley-druckenmiller) 0.2%
- [Joel Greenblatt](https://funkfolio.com/gurus/joel-greenblatt) 0.2%
- [Paul Tudor Jones](https://funkfolio.com/gurus/paul-tudor-jones) 0.1%

Percentages are each holding's share of that investor's reported portfolio (under "Both": Gilead Sciences / Thermo Fisher Scientific). [Who owns GILD](https://funkfolio.com/stock/GILD/superinvestors) · [Who owns TMO](https://funkfolio.com/stock/TMO/superinvestors)

### More on Gilead Sciences

- [Gilead Sciences (GILD) stock page](https://funkfolio.com/stock/GILD)
- [Gilead Sciences market cap](https://funkfolio.com/stock/GILD/market-cap)
- [Gilead Sciences revenue](https://funkfolio.com/stock/GILD/revenue)
- [Gilead Sciences P/E ratio](https://funkfolio.com/stock/GILD/pe-ratio)
- [Gilead Sciences operating margin](https://funkfolio.com/stock/GILD/operating-margin)
- [Gilead Sciences total debt](https://funkfolio.com/stock/GILD/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on Thermo Fisher Scientific

- [Thermo Fisher Scientific (TMO) stock page](https://funkfolio.com/stock/TMO)
- [Thermo Fisher Scientific market cap](https://funkfolio.com/stock/TMO/market-cap)
- [Thermo Fisher Scientific revenue](https://funkfolio.com/stock/TMO/revenue)
- [Thermo Fisher Scientific P/E ratio](https://funkfolio.com/stock/TMO/pe-ratio)
- [Thermo Fisher Scientific operating margin](https://funkfolio.com/stock/TMO/operating-margin)
- [Thermo Fisher Scientific total debt](https://funkfolio.com/stock/TMO/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### Gilead Sciences against its closest peers

- [Gilead Sciences vs Amgen](https://funkfolio.com/compare/amgn-vs-gild)
- [Gilead Sciences vs Abbott Laboratories](https://funkfolio.com/compare/abt-vs-gild)
- [Gilead Sciences vs Novo Nordisk](https://funkfolio.com/compare/gild-vs-nvo)

#### Thermo Fisher Scientific against its closest peers

- [Thermo Fisher Scientific vs Amgen](https://funkfolio.com/compare/amgn-vs-tmo)
- [Thermo Fisher Scientific vs AstraZeneca](https://funkfolio.com/compare/azn-vs-tmo)
- [Thermo Fisher Scientific vs Novartis](https://funkfolio.com/compare/nvs-vs-tmo)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, Gilead Sciences or Thermo Fisher Scientific?**

By market value, Thermo Fisher Scientific is the larger: $254.5B against $211.2B for Gilead Sciences. By revenue in its latest fiscal year, Thermo Fisher Scientific is the larger: $44.6B against $29.4B for Gilead Sciences.

**Which has the higher operating margin?**

Gilead Sciences: 34.0%, against 17.4% for Thermo Fisher Scientific. Operating margin is operating income as a share of revenue in the latest fiscal year.

**Which has the higher dividend yield?**

Gilead Sciences: 1.94%, against 0.27% for Thermo Fisher Scientific. Dividend yield is the last twelve months' dividends as a share of today's share price.

**Which has more debt?**

Thermo Fisher Scientific: $39.4B, against $24.9B for Gilead Sciences. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

**Which superinvestors own both Gilead Sciences and Thermo Fisher Scientific?**

In their latest 13F filings, Dodge & Cox team, Steve Cohen, Ken Griffin and David Shaw (founder) hold both.

### Cite this page

Funkfolio, “Gilead Sciences vs Thermo Fisher Scientific”, data as of 18 November 2026. https://funkfolio.com/compare/gild-vs-tmo

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
